Diabetes · 2024 · 14 citations · 12 references
MedicineChronic Disease PreventionDiabetologyEarly DetectionRisk AssessmentCardiovascular DiseaseCardiovascular RiskDiabetes ControlDiabetes MellitusGlycemic ControlGlycemic MonitoringCardiovascular Disease IncidenceCox RegressionDiabetes-associated Cardiac RiskEarly Clinical ExposureGlycemic Control TargetsGlycemic TargetsIntensive Glycemic ControlType 2 Diabetes Risk Reduction
Early, intensive glycemic control in patients with type 2 diabetes (T2D) is associated with long-term benefits in cardiovascular disease (CVD) development. Evidence on benefits of achieving HbA1c targets close to normal values is scant. Individuals with newly diagnosed T2D, without CVD at baseline, were identified in an Italian clinical registry (n = 251,339). We adopted three definitions of early exposure periods (0-1, 0-2, and 0-3 years). Mean HbA1c was categorized into HbA1c <5.7%, 5.7-6.4%, 6.5-7.0%, 7.1-8.0%, and >8.0%. The outcome was the incidence of major cardiovascular events. After a mean follow-up of 4.6 ± 2.9 years, at multivariate Cox regression analysis, compared with mean HbA1c <5.7% during the first year after diagnosis, the increase in the risk of CVD was 24%, 42%, 49%, and 56% for patients with HbA1c of 5.7-6.4%, 6.5-7.0%, 7.1-8.0%, and >8.0%, respectively. The same trend was documented in all exposure periods. In conclusion, our data support that an early achievement of stringent targets of HbA1c <5.7% is worthy for CVD prevention.
12
Severe Hypoglycemia and Risks of Vascular Events and Death
Sophia Zoungas, Anushka Patel, John Chalmers et al. · New England Journal of Medicine · 2010 · 1.5K citations · Full text
Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 Diabetes
Sophia Zoungas, John Chalmers, Bruce Neal et al. · New England Journal of Medicine · 2014 · 624 citations · Full text
David R. Matthews, Päivi M. Paldánius, Pieter Proot et al. · The Lancet · 2019 · 355 citations
Sanjoy K. Paul, Kerenaftali Klein, Brian Larsen Thorsted et al. · Cardiovascular Diabetology · 2015 · 297 citations · Full text
Medicine, Internal Medicine, Cardiovascular Pharmacotherapy +16